Boots announces it will begin prescribing medical cannabis in the UK through an online service called SureLeaf. Several outlets describe it as a first for a major UK high street pharmacy, saying access will be limited to patients aged 25 and over with eligible conditions.

Across the reports, eligible conditions mentioned include chronic pain, anxiety and insomnia, with additional examples such as insomnia-related symptoms and forms of pain tied to conditions like fibromyalgia or osteoarthritis. Multiple outlets also note that patients must have tried conventional treatments first without adequate symptom relief.

Outlets also frame the service in different ways. Business of Fashion adds that Boots is launching SureLeaf alongside the University of Nottingham. Right-leaning coverage from the Mail and Daily Mail highlights a cost figure for prescriptions (£40) and presents the initiative as Boots being first on the high street to sell the drug. Other reports focus more generally on eligibility, noting that certain underlying health conditions can disqualify patients.